Search research articles
Contact Us
Filters
Showing results (21-30 of 230) with videos related to
Page
of 23
Sort By:
Frontiers in Plant Science
|
December 21, 2020
A Roadmap for the Molecular Farming of Viral Glycoprotein Vaccines: Engineering Glycosylation and Glycosylation-Directed Folding
Emmanuel Margolin, Max Crispin, Ann Meyers, et al.
Analytical and Bioanalytical Chemistry
|
July 30, 2021
Identification of N-glycans with GalNAc-containing antennae from recombinant HIV trimers by ion mobility and negative ion fragmentation
David J Harvey, Anna-Janina Behrens, Max Crispin, et al.
Journal of Molecular Biology
|
April 28, 2019
Protein and Glycan Mimicry in HIV Vaccine Design
Gemma E Seabright, Katie J Doores, Dennis R Burton, et al.
Biochemical Society Transactions
|
May 23, 2018
Harnessing post-translational modifications for next-generation HIV immunogens
Joel D Allen, Rogier W Sanders, Katie J Doores, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy
|
May 4, 2017
Improving Antibody-Based Cancer Therapeutics Through Glycan Engineering
Xiaojie Yu, Michael J E Marshall, Mark S Cragg, et al.
Transfusion
|
March 11, 2015
A monoclonal antibody with anti-D-like activity in murine immune thrombocytopenia requires Fc domain function for immune thrombocytopenia ameliorative effects
Xiaojie Yu, Melissa Menard, Gemma Seabright, et al.
Science (New York, N.Y.)
|
May 6, 2020
Site-specific glycan analysis of the SARS-CoV-2 spike
Yasunori Watanabe, Joel D Allen, Daniel Wrapp, et al.
ACS Chemical Biology
|
December 17, 2016
Global N-Glycan Site Occupancy of HIV-1 gp120 by Metabolic Engineering and High-Resolution Intact Mass Spectrometry
Weston B Struwe, Alexandra Stuckmann, Anna-Janina Behrens, et al.
Journal of Molecular Biology
|
December 19, 2020
Subtle Influence of ACE2 Glycan Processing on SARS-CoV-2 Recognition
Joel D Allen, Yasunori Watanabe, Himanshi Chawla, et al.
Science (New York, N.Y.)
|
January 4, 2014
Emerging principles for the therapeutic exploitation of glycosylation
Martin Dalziel, Max Crispin, Christopher N Scanlan, et al.
Page
of 23
Search research articles
Search
Showing results (21-30 of 230) with videos related to
Sort By:
Page
of 23
Frontiers in Plant Science
|
December 21, 2020
A Roadmap for the Molecular Farming of Viral Glycoprotein Vaccines: Engineering Glycosylation and Glycosylation-Directed Folding
Emmanuel Margolin, Max Crispin, Ann Meyers, et al.
Analytical and Bioanalytical Chemistry
|
July 30, 2021
Identification of N-glycans with GalNAc-containing antennae from recombinant HIV trimers by ion mobility and negative ion fragmentation
David J Harvey, Anna-Janina Behrens, Max Crispin, et al.
Journal of Molecular Biology
|
April 28, 2019
Protein and Glycan Mimicry in HIV Vaccine Design
Gemma E Seabright, Katie J Doores, Dennis R Burton, et al.
Biochemical Society Transactions
|
May 23, 2018
Harnessing post-translational modifications for next-generation HIV immunogens
Joel D Allen, Rogier W Sanders, Katie J Doores, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy
|
May 4, 2017
Improving Antibody-Based Cancer Therapeutics Through Glycan Engineering
Xiaojie Yu, Michael J E Marshall, Mark S Cragg, et al.
Transfusion
|
March 11, 2015
A monoclonal antibody with anti-D-like activity in murine immune thrombocytopenia requires Fc domain function for immune thrombocytopenia ameliorative effects
Xiaojie Yu, Melissa Menard, Gemma Seabright, et al.
Science (New York, N.Y.)
|
May 6, 2020
Site-specific glycan analysis of the SARS-CoV-2 spike
Yasunori Watanabe, Joel D Allen, Daniel Wrapp, et al.
ACS Chemical Biology
|
December 17, 2016
Global N-Glycan Site Occupancy of HIV-1 gp120 by Metabolic Engineering and High-Resolution Intact Mass Spectrometry
Weston B Struwe, Alexandra Stuckmann, Anna-Janina Behrens, et al.
Journal of Molecular Biology
|
December 19, 2020
Subtle Influence of ACE2 Glycan Processing on SARS-CoV-2 Recognition
Joel D Allen, Yasunori Watanabe, Himanshi Chawla, et al.
Science (New York, N.Y.)
|
January 4, 2014
Emerging principles for the therapeutic exploitation of glycosylation
Martin Dalziel, Max Crispin, Christopher N Scanlan, et al.
Page
of 23